Catalyst Capital Advisors LLC Corcept Therapeutics Inc Transaction History

Catalyst Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$12.46 - $19.98 $1,993 - $3,196	-160 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$10.11 - $14.04 $6,470 - $8,985	-640 Reduced 80.0%	160 $2,000
Q2 2019 Aug 08, 2019	SELL	$9.78 - $12.76 $145,722 - $190,124	-14,900 Reduced 94.9%	800 $9,000
Q1 2019 May 08, 2019	SELL	$10.03 - $15.71 $684,046 - $1.07 Million	-68,200 Reduced 81.29%	15,700 $184,000
Q4 2018 Feb 07, 2019	BUY	$11.29 - $17.19 $947,230 - $1.44 Million	83,900 New	83,900 $1.12 Million
Q2 2018 Aug 07, 2018	SELL	$15.3 - $19.69 $82,620 - $106,326	-5,400 Closed	0 $0
Q1 2018 May 18, 2018	SELL	$14.59 - $25.5 $911,875 - $1.59 Million	-62,500 Reduced 92.05%	5,400 $89,000
Q4 2017 Feb 08, 2018	SELL	$15.77 - $20.72 $67,022 - $88,060	-4,250 Reduced 5.89%	67,900 $1.23 Million
Q3 2017 Nov 08, 2017	BUY	$12.3 - $19.3 $887,445 - $1.39 Million	72,150	72,150 $1.39 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.